Market analysis of growing competition in pharmaceutical industry
by Paola Cavazzani, Rajagopal
International Journal of Business Competition and Growth (IJBCG), Vol. 1, No. 1, 2010

Abstract: This paper discusses the consumer behaviour towards in buying pharmaceutical products in Mexico, which is price-sensitive, and generic medicines are setting major competitive challenges in the pharmaceutical marketing. It is argued in the paper that the attribute of self-medication and search for low-price alternatives against prescribed medicines have given the opportunity for generic pharmaceuticals to enter the market competition in Mexico. The domestic firms, most of which are engaged in manufacturing generic medicines through retail pharmacy network, enjoy higher efficiencies than affiliates of major multinational pharmaceutical companies. This paper analyses the market competition between generic and commercial pharmaceutical brands in the context of buyers and distributors bargaining power, substitution effect and challenges from new entrants in the Mexican pharmaceutical market.

Online publication date: Sun, 25-Apr-2010

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Business Competition and Growth (IJBCG):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com